Endothelium-Derived Vasoactive Substances in Bartter's Syndrome

Angiology

Volumn 46, Issue 10, 1995, Pages 905-913

  Calò, Lorenzo ^a   Cantaro, Salvatore ^a   Rizzolo, Monica ^a   Favaro, Silvana ^a   Antonello, Augusto ^a   Borsatti, Arturo ^a   Calabrò, Alessio ^a   Piarulli, Francesco ^a   Crepaldi, Gaetano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENDOTHELIN; NITRATE; NITRIC OXIDE; NITRITE;

ADOLESCENT; ADULT; ARTICLE; BARTTER SYNDROME; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; URINARY EXCRETION;

ADOLESCENT; ADULT; BARTTER'S DISEASE; ENDOTHELINS; FEMALE; FOREARM; HUMAN; MALE; MIDDLE AGE; NITRATES; NITRIC OXIDE; NITRITES; REGIONAL BLOOD FLOW; SUPPORT, NON-U.S. GOV'T;

EID: 0028884034     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/000331979504601005     Document Type: Article

References (34)

1. Marsden PA, Brenner BM: Nitric oxide and endothelins: Novel autocrine/paracrine regulators of the circulation. Seminars in Nephrol 11: 169-185, 1991.
2. Bartter FC: Bartter's syndrome: A disorder of vascular reactivity. Hypertension 3: 69-73, 1981.
3. Zipser RD, Rude RK, Zia PK, et al: Regulation of urinary prostaglandins in Bartter's syndrome. Am J Med 67: 263-267, 1979.
4. Delaney VB, Oliver JF, Simms M., et al: Bartter's syndrome: Physiological and pharmacological studies. Q J Med 198: 213-232, 1981.
5. Antonucci F., Bertolissi M., Calo' L: Plasma endothelin and renal function during infrarenal aortic cross-clamping and nifedipine infusion (letter). Lancet 336: 1449, 1990.
6. Hirooka Y., Takeshita A., Imaizumi T.: Attenuated forearm vasodilatative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation 87: 147-153, 1990.
7. Calabrò A., Piarulli F., Milan D., et al: Clinical assessment of low molecular weight heparin effects in peripheral vascular disease. Angiology 44: 188-194, 1993.
8. Bartter FC, Pronove P., Gill JR, et al: Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: A new syndrome. Am J Med 33: 811-828, 1967.
9. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcoline. Nature 288: 373-376, 1980.
10. Furchgott RF : Role of endothelium in responses of vascular smooth muscle. Circ Res 53: 557-578, 1983.
11. Miller WL, Redfield MM, Burnett JC Jr: Integrated cardiac, renal and endocrine actions of endothelin. J Clin Invest 83: 317-320, 1989.
12. Cavero P., Miller W., Hemblein D., et al: Endothelin in experimental congestive heart failure. Am J Physiol 259: F312-F317, 1990.
13. Kamoi K., Ishibashi M., Yamaji T.: Plasma endothelin-1 levels in patients with hyponatremia. Nephron 62: 469-470, 1992.
14. Boer P., Hene' RJ, Koomans HA, et al: Blood and extracellular fluid volume in patients with Bartter's syndrome. Arch Intern Med 143: 1902-1905, 1983.
15. Yamada K., Yoshida S.: Role of endogenous endothelin on renal functions in rats. Am J Physiol 260: F34-F38, 1991.
16. Yanagisawa M., Kurihata H., Kamura S., et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
17. Richards CJ, Mark AL, Van Orden DE, et al: Effect of indomethacin on the vascular abnormalities of Bartter's syndrome. Circulation 58: 544-549, 1978.
18. Di Virgilio F., Calo' L., Cantaro S., et al: Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Clin Sci 72: 483-488, 1987.
19. Ciedel CL: Regulation of vascular smooth muscle contraction. Fed Proc 43: 2390-2398, 1984.
20. Highsmith RF, Pang DC, Rapoport RM: Endothelial cell-derived vasoconstrictors: Mechanism of action in vascular smooth muscle. J Cardiovasc Pharmacol 13: 36-44, 1989.
21. Wallnofer A., Weir S., Ruegg U., et al: The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle. J Cardiovasc Pharmacol 13: 23-31, 1989.
22. Moncada S., Higgs A.: The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
23. Hishikawa K., Nakaki T., Suzuki H., et al: L-arginine-induced hypotension. Lancet 337: 683-684, 1991.
24. Moncada S.: The first Robert Furchgott Lecture: From endothelium-dependent relaxation to the L-arginine:NO pathway. Blood Vessels 27: 208-217, 1990.
25. Suzuki H., Ikenaga H., Hishikawa K., et al: Increases in NO2-/NO3- excretion in the urine as an indicator of the release of endothelium derived relaxing factor during elevation of blood pressure. Clin Sci 82: 631-634, 1992.
26. Panza JA, Quyyumi AA, Brush JE, et al: Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990.
27. Pinto A., Sorrentino R., Sorrentino P., et al: Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 164: 507-513, 1991.
28. Petros A., Bennett D., Vallance P.: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557-1558, 1991.
29. Moncada S.: The L-arginine:nitric oxide pathway. Acta Physiol Scand 145: 201-227, 1992.
30. Amir S., English AM: An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. Eur J Pharmacol 203: 125-127, 1991.
31. Guarner C., Soriano G., Tomas A., et al: Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship with endotoxemia. Hepatology 18: 1139-1143, 1993.
32. Lopez-Jaramillo P., Gonzales MC, Palmer Rmj, et al: The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol 101: 489-493, 1990.
33. Busse R., Mulsch A.: Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 265: 133-136, 1990.
34. Calò L., Cantaro S., Vianello A., Favaro S., et al: Platelet calmodulin concentration in essential hypertension and in Bartter's syndrome. Am J Nephrol 6: 60-62, 1986.